New cancer drug trial halted early – what we know
NCT ID NCT06331559
First seen Feb 12, 2026 · Last updated May 01, 2026 · Updated 11 times
Summary
This early-stage trial tested a new drug called SIM0501, alone or with another drug (olaparib), in 13 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check safety and how the drug moves through the body. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shandong Cancer Hospital
Jinan, Shandong, 250117, China
Conditions
Explore the condition pages connected to this study.